Female Contraception Clinical Trial
Official title:
The Influence of Oral Contraceptives on Mood, Sexuality and Economic Behavior
The investigators aim is to evaluate effects of combined oral contraceptives (OC) on mood, sexuality and economic behaviour in a randomized, double-blind, placebo-controlled study. 400 healthy women will be randomized to OC or placebo for a period of three months. Before and at the end of treatment, mood and sexuality will be assessed by validated instruments. At the end of treatment, each woman will participate in behavioral experiments testing self-confidence, risk taking and altruism. The current project could fill the gap of ignorance about causal effects of OCs on mood, sexuality and behavior. The results might improve current practice as regards information about OCs, choice of hormonal contraceptive, regimen and duration of use. As a consequence, this could lead to reduced discontinuation rate, fewer unintended pregnancies and abortions. The project will contribute to an overall improvement in women's reproductive health.
n/a
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT06394999 -
Efficacy, Safety, and Acceptability of Mifepristone 50 mg Once-weekly as a Contraceptive
|
Phase 3 | |
| Completed |
NCT00653016 -
An Open-label, Multicentre Study on Preference and Satisfaction of Canadian Women for the Transdermal Contraceptive Patch vs. Previous Primary Contraceptive Method
|
Phase 4 | |
| Completed |
NCT00511784 -
Relative Risks for Non-fatal Venous Thromboembolism, Ischemic Stroke and Myocardial Infarction in Users of ORTHO EVRA(Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared to Levonorgestrel-containing Oral Contraceptives.
|
N/A | |
| Completed |
NCT00236769 -
A Study of Efficacy and Safety With the Transdermal Contraceptive System.
|
Phase 3 | |
| Active, not recruiting |
NCT03124160 -
Compare Two Copper IUDs: Mona Lisa NT Cu380 Mini and ParaGard
|
Phase 3 | |
| Completed |
NCT00709189 -
Bioequivalence Study of the Oral Contraceptive Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women.
|
Phase 1 | |
| Completed |
NCT00258063 -
A Study to Evaluate the Exposure of Norelgestromin and Ethinyl Estradiol From Commercial Lots of EVRA (a Transdermal Contraceptive Patch Manufactured by LOHMANN Therapie-Systeme) and CILEST (an Oral Contraceptive)
|
Phase 1 | |
| Completed |
NCT00775086 -
Bioequivalence Study of Patches With Different Equilibration Profiles
|
Phase 1 | |
| Recruiting |
NCT04143659 -
A Study to Evaluate the PK and PD of IM or SQ Injections of Levonorgestrel Butanoate (LB) for Female Contraception
|
Phase 1 | |
| Completed |
NCT00697307 -
Bioequivalence Study of Patches With Different Release Profiles
|
N/A | |
| Completed |
NCT00261482 -
Evaluation of Women's Experience With EVRA (Norelgestromin + Ethinyl Estradiol) Transdermal Contraceptive Patch Compared With Previous Methods of Contraception.
|
Phase 4 | |
| Completed |
NCT01286948 -
Prevention of Ovulation Achieved by Single Intra-vaginal Administration of Levogel as Compared to Oral LNG
|
Phase 1 | |
| Completed |
NCT00236795 -
A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Triphasil.
|
Phase 3 | |
| Completed |
NCT01833793 -
Descriptive, Prospective, Non-interventional Study (NIS) to Describe Mirena and Amenorrhea Related Acceptability in Contraception Indication in Medical Practice
|
N/A | |
| Recruiting |
NCT03432416 -
Study of Efficacy, Cycle Control, and Safety of a NES-E2 Contraceptive Vaginal Ring
|
Phase 2 | |
| Completed |
NCT01178125 -
A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy
|
Phase 3 | |
| Completed |
NCT00254865 -
A Comparative Pharmacokinetic Study of ORTHO EVRA (a Transdermal Contraceptive Patch) and CILEST (an Oral Contraceptive) in Healthy Female Volunteers
|
Phase 1 | |
| Completed |
NCT00258076 -
A Study to Evaluate the Hormone Exposure From Multiple Commercial Lots of ORTHO EVRA (a Transdermal Contraceptive Patch)
|
Phase 1 | |
| Completed |
NCT00377988 -
A Postmarketing Study of the Risk of Venous Thromboembolism (Blood Clots), Myocardial Infarction (Heart Attacks), and Stroke Among Women Using ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared With Women Who Take Oral Contraceptives for Birth Control
|
N/A | |
| Completed |
NCT00331071 -
Postmarketing Study of ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) in Relation to Venous Thromboembolism (Blood Clots), Stroke and Heart Attacks
|
N/A |